Venatorx

US-based, clinical stage biotech developing beta-lactamase inhibitors for DR infections

placeMalvern, Pennsylvania, United States calendar_todayFounded 2010 groups80 employees language venatorx.com

Registered entities

Investor mix

9 investors on record; lead investors include Wellcome, AMR Action Fund, Versant Ventures.

Investor typeCountShare
Venture capital556%
Other / undisclosed444%
Coming soon